India’s Use of Patent Opposition Mechanism as an Access to Drugs Strategy: An Empirical Analysis. (2024). Journal of Intellectual Property Rights (JIPR), 29(4), 253-264. https://doi.org/10.56042/jipr.v29i4.3704